Enabling AI-Powered Transformation in Life Sciences (Presented by Dataiku)

There has been an unprecedented focus on embedding AI across every facet of the biopharmaceutical value chain, and top global organizations are leveraging the Dataiku platform, supercharged by NVIDIA technologies, to achieve this transformation. Large models (LxMs), particularly large language models (LLMs), have proved to be an inflection point to engage and integrate business and data teams to achieve strategic objectives across the drug life cycle. This collaborative approach promises to reshape not just AI-driven drug discovery and development but all areas of clinical operations, manufacturing, market launch, and engagement as the volume and granularity of data explodes in this industry. We'll delve into real-world applications where Dataiku can bring GPU-accelerated data flows and API services and libraries such as NVIDIA BioNemo, MONAI, and Rapids not only to data engineers but to scientists, engineers, clinical operations, medical affairs, and market engagement teams alike.